|
Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men. Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men. conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men. Clinical research trials and Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men. healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men.. Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men. Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men. clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men. condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men.  Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men.
Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men.
For Condition: Osteoporosis
Status: Completed
Sponsor(s): Department of Veterans Affairs , Department of Veterans Affairs Cooperative Studies Program
Synopsis: The goals of this project are to establish a new cohort of male veterans and describe associations between potential risk factors and baseline bone mineral density (BMD) as well as rates of BMD loss.
Details: Primary Hypothesis: Risk factors such as smoking, alcohol, and caffeine are associated with osteoporosis in men. Intervention: None Primary Outcomes: Percent reduction in cross-sectional bone mineral density over time. Study Abstract: The goals of this project are to establish a new cohort of male veterans and describe associations between potential risk factors and baseline bone mineral density (BMD) as well as rates of BMD loss. The study is a two-year observational prospective study of 1000 male veterans aged 50 and older. The subjects are drawn from two existing VA cohorts, the Normative Aging Study (NAS) and the Veterans Health Study (VHS). Examinations to be performed on each subject (baseline and two follow-up exams) include BMD measurement at the hip, forearm and total body, anthropometry, hand grip strength, and questionnaires on current diet, physical activity, tobacco, alcohol use, sunlight exposure, health related quality of life (Medical Outcomes Study Short Form), depression (Brief Depression Scale), fracture history, medications and psychological factors (PrimeMD, MiniMental). Additional data on historical exposure to risk factors, previously obtained in the NAS or VHS studies, will also be correlated with BMD and BMD loss. Multivariate linear and logistic models with control for potential confounders will be used in the main analyses. Examinations take place at the Boston VA Outpatient Clinic. Examinations on each subject include BMD measurement at the hip, forearm and total body, height and weight, hand grip strength, leg extensor strength, and mobility. Questionnaires on current diet, physical activity, tobacco, alcohol use, sunlight exposure, health related quality of life (Medical Outcomes Study Short Form), depression (Brief Depression Scale), fracture history, medications and psychological factors (PrimeMD, MiniMental) are administered. Each subject also contributes a nonfasting blood sample and a 24-hour urine sample. Beginning in April, 1999, two additional measures are being obtained as a result of a 4-year supplemental VA Epidemiology grant awarded to Dr. Miller. These are the heel ultrasound measure and a 4-day physical activity level determined by ambulatory monitor. Preliminary cross-sectional analysis of mean BMD for femoral neck, total body and forearm BMD suggest the percent reduction in cross-sectional BMD between ages 60-69 and 80-89 is approximately 9% per decade at the femoral neck, 5%/decade at the total body, and 8%/decade at the forearm. These age-related patterns agree well with other studies of BMD in older men. The x-ray densitometer was installed at the Boston VA Outpatient Clinic in April, 1998 and the study technician was certified for bone density measurements during the three-day training session that followed. A precision study was conducted in the following month. In vivo reproducibility was determined by performing 5 repeat scans of each of the three sites on 5 volunteers ranging in age from 21 to 50 years. Subjects were repositioned between each scan. The coefficient of variation (CV) of femoral neck BMD in our laboratory is 0.92%; for whole body BMD, 0.72%; and for distal radius BMD, 1.04%. An aluminum spine phantom with known density (1.254 gm/cm2) is scanned every two weeks on the DPX-IQ. The mean ? standard deviation of 15 measurements is 1.250 ? 0.0058, coefficient of variation = 0.46%. There has been no detectable drift in phantom values during the study start-up phase. When completed, this study will be one of the largest in the US to study risk factors for osteoporosis in men, historically an understudied group in relation to osteoporosis. Several of the hypothesized risk factors (smoking, alcohol, caffeine, for example) are amenable to change and represent potential areas of intervention. Thus, not only can the VA make a valuable contribution to furthering our understanding of osteoporosis in men in general, but strategies may be identified to reduce morbidity as well as reduce health care costs associated with fracture in the elderly.
Eligibility:
Study Type: Observational, Natural History, Convenience Sample
Minimum Age/Maximum Age: 50 Years/
Genders: Male
Protocol Entry Criteria: Veterans aged 50 and older drawn from two existing VA cohorts, the Normative Aging Study (NAS) and the Veterans Health Study (VHS).
Total Enrollment: 1000
Location and Contact Information:
Boston VA Health Care System
Jamaica Plain, Massachusetts, 02130
United States
Additional Information:
Study ID Numbers: 714B;
Study Start Date: June 1998
Record last reviewed: February 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00011323
Other Osteoporosis Studies:
1. Parathyroid Hormone (PTH) with Alendronate for Osteoporosis
2. Preventing Osteoporosis in Adolescent Girls
3. Treatment of Childhood Osteoporosis with Alendronate (Fosamax)
4. Comparison of Study Drug With Alendronate on How it Effects Glucocorticoid-Induced Osteoporosis
5. Phase 2 Study assessing AMG 162 in the treatment of women with low bone density
Related Studies:
Other Osteoporosis Clinical Trials
Other Massachusetts Clinical Trials
Other Jamaica Plain Clinical Trials
Determining the risk factors such as smoking, alcohol, and caffeine and their association with osteoporosis in men.
|
|
|
|
|
|
|
|
